Pancreatic Cancer is an aggressive and quickly spreading disease where few symptoms exist until the cancer is very advanced, creating a poor prognosis even with early detection. It occurs when malignant cells form in the tissues of the pancreas, typically in the exocrine cells (the cells that produce digestive juices). Pancreatic cancer typically affects individuals who are African American, who are overweight, have diabetes, smoke, have pancreatitis, or have a family history of pancreatic cancer. Treatments for pancreatic cancer include surgery, radiation therapy, chemotherapy, targeted therapy, and clinical trials. Resectable pancreatic cancer is defined as cancer that is surgically removable because it is localized to the pancreas, not developing into surrounding structures like blood sources. Additionally, the cancer cannot have metastasized to other organs or tissues to be considered resectable. To perform the removal of pancreatic cancer, a whipple operation, pancreatectomy, or a splenectomy are common techniques.
Resectable Pancreatic Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Resectable Pancreatic Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 1220 products for the study of Resectable Pancreatic Cancer that can be applied to Western Blot, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.